![Imperial’s COVID-19 vaccine moves to next phase](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1594919024943_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
Clinical progress
Imperial’s COVID-19 vaccine moves to next phase
Clinical trials to test a new coronavirus vaccine developed by researchers at Imperial College London are progressing to the next phase.
Imperial’s COVID-19 vaccine moves to next phase
Clinical trials to test a new coronavirus vaccine developed by researchers at Imperial College London are progressing to the next phase.
Video
Everything you need to know about Imperial’s COVID-19 vaccine trial
With trials now under way, get up to speed with the development and testing of Imperial’s COVID-19 vaccine
9
Imperial academics share latest COVID-19 research with international community
Imperial researchers working on coronavirus shared their latest work with an international community of diplomats, academics, and science attachés.
Video
Imperial’s COVID-19 vaccine trial: how will it work?
Dr Hannah Cheeseman breaks down some of the key questions surrounding Imperial's COVID-19 vaccine study, which launched last week.
4
First volunteers receive Imperial COVID-19 vaccine
The first healthy volunteers have now received a candidate coronavirus vaccine developed by Imperial researchers.
1
Audio
Podcast: Vaccine production, safety on public transport, and emerging economies
In this edition: How to make a billion COVID-19 vaccines, why women feel unsafe on public transport, and how emerging economies fare under COVID-19.
What policy makers need to know about COVID-19 protective immunity
“Few would disagree that science should guide the clinical therapeutic approach to an infected person. Science must also guide policy decisions.”
Feature
Is the world ready to produce a billion doses of a COVID-19 vaccine?
Imperial researchers say integrated modelling and flexible planning will be essential for
manufacturers to meet the global COVID-19 vaccine demand.
NIHR Imperial Clinical Research Facility: the London site for the Oxford COVID-1
The NIHR ICRF has begun London based screening for the Oxford COVID-19 vaccine clinical trial which was launched last week.
Feature
Lockdown advice from a GP: Stay active, keep in touch, don’t ignore vaccinations
From the start of the coronavirus outbreak, much of the focus has been the acute impact of COVID-19 on critical care capacity in hospitals.